Chemotherapy-induced reversal of ciltacabtagene autoleucel-associated movement and neurocognitive toxicity-Reference-Cited by-同舟云学术

Chemotherapy-induced reversal of ciltacabtagene autoleucel-associated movement and neurocognitive toxicity

Published:2023-07-19 Issue: Volume: Page:
ISSN:0006-4971
Container-title:Blood Journal
language:en
Short-container-title:

Author:

Graham Charlotte E¹^ORCID,Lee Won-Ho²^ORCID,Wiggin Hadley R²,Supper Valentina M³^ORCID,Leick Mark B¹^ORCID,Birocchi Filippo¹^ORCID,Yee Andrew J.¹,Petrichenko Angelina⁴^ORCID,Everett John K⁴,Bushman Frederic D.⁴,Sadrzadeh Hossein³,Rapalino Otto⁵^ORCID,Chiu Daniel¹,Arrillaga-Romany Isabel C¹,Maus Marcela V¹^ORCID,Frigault Matthew J¹,Gallagher Kathleen M E¹

Affiliation:

1. Harvard Medical School, United States

2. Massachusetts General Hospital, Charlestown, Massachusetts, United States

3. Massachusetts General Hospital, Boston, Massachusetts, United States

4. University of Pennsylvania, Philadelphia, Pennsylvania, United States

5. Harvard Medical School

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

https://ashpublications.org/blood/article-pdf/doi/10.1182/blood.2023021429/2065098/blood.2023021429.pdf

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies;Blood;2024-09-12

2. CAR T-cell toxicities: from bedside to bench, how novel toxicities inform laboratory investigations;Blood Advances;2024-08-16

3. Parkinsonism Following Chimeric Antigen Receptor T Cell Therapy;JAMA Neurology;2024-08-12

4. Bispecific antibodies and autologous chimeric antigen receptor T cell therapies for treatment of hematological malignancies;Molecular Therapy;2024-08

5. Parkinson‐like neurotoxicity in female patients treated with idecabtagene‐vicleucel;HemaSphere;2024-07